Volume 24, Issue 3 (Iranian South Medical Journal 2021)
Iran South Med J 2021, 24(3): 160-171 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Asad Samani M, Reiisi S, Riahi N, Kabiri S. SoxC (sox4, sox11, sox12) Gene Expression in MS Patients. Iran South Med J 2021; 24 (3) :160-171
URL: http://ismj.bpums.ac.ir/article-1-1472-en.html
URL: http://ismj.bpums.ac.ir/article-1-1472-en.html
1- Department of Genetic, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran
2- Department of Genetics, School of Basic Sciences, Shahrekord University, Shahrekord, Iran , s.reiisi@ sku.ac.ir
2- Department of Genetics, School of Basic Sciences, Shahrekord University, Shahrekord, Iran , s.reiisi@ sku.ac.ir
Abstract: (2315 Views)
Background: Sox genes are growth regulators that serve functions in sex determination, neural crest development, and neurogenesis. SoxC proteins include Sox4, Sox11, and Sox12, which cause the development of neural progenitor cells to immature neurons. In other words, one of the functions of these factors is the role they play in neurogenesis. Therefore, the aim of this study was to investigate the changes in the expression of SoxC genes in Multiple Sclerosis (MS).
Materials and Methods: This descriptive-analytical study seeks to evaluate the relative expression of SoxC genes. For this purpose, blood samples from 40 patients with MS and 40 healthy controls were examined. Total RNA extraction and complementary DNA synthesis (cDNA) were then performed, and the relative expression of the three genes Sox4, Sox11 and Sox12 was then obtained by real-time PCR. The data collected were analyzed using statistical methods.
Results: The results showed that the expression of Sox4, Sox11 and Sox12 genes were significantly downregulated in the patients with MS compared to the controls (P=0.009, P=0.019, and P=0.001). Also, with increasing disability in individuals with MS, gene expression decreased significantly for Sox4 and Sox11, but the change was not significant for Sox12.
Conclusion: The present study revealed that the expression of SoxC genes is lower in MS. Considering the functional role of Sox genes as proteins involved in neurogenesis, the abnormal expression of members of this gene family is implicated in various diseases.
Materials and Methods: This descriptive-analytical study seeks to evaluate the relative expression of SoxC genes. For this purpose, blood samples from 40 patients with MS and 40 healthy controls were examined. Total RNA extraction and complementary DNA synthesis (cDNA) were then performed, and the relative expression of the three genes Sox4, Sox11 and Sox12 was then obtained by real-time PCR. The data collected were analyzed using statistical methods.
Results: The results showed that the expression of Sox4, Sox11 and Sox12 genes were significantly downregulated in the patients with MS compared to the controls (P=0.009, P=0.019, and P=0.001). Also, with increasing disability in individuals with MS, gene expression decreased significantly for Sox4 and Sox11, but the change was not significant for Sox12.
Conclusion: The present study revealed that the expression of SoxC genes is lower in MS. Considering the functional role of Sox genes as proteins involved in neurogenesis, the abnormal expression of members of this gene family is implicated in various diseases.
Type of Study: Original |
Subject:
General
Received: 2021/03/19 | Accepted: 2021/06/21 | Published: 2021/09/1
Received: 2021/03/19 | Accepted: 2021/06/21 | Published: 2021/09/1
References
1. Schepers GE, Teasdale RD, Koopman P. Twenty Pairs Of Sox: Extent, Homology, And Nomenclature Of The Mouse And Human Sox Transcription Factor Gene Families. Dev Cell 2002; 3(2): 167-70.
2. De La Rocha AMA, Sampron N, Alonso MM, et al. Role Of Sox Family Of Transcription Factors In Central Nervous System Tumors. Am J Cancer Res 2014; 4(4): 312-24.
3. Sarkar A, Hochedlinger K. The Sox Family Of Transcription Factors: Versatile Regulators Of Stem And Progenitor Cell Fate. Cell Stem Cell 2013; 12(1): 15-30.
4. Pevny L, Placzek M. Sox Genes And Neural Progenitor Identity. Curr Opin Neurobiol 2005; 15(1): 7-13.
5. Dy P, Penzo-Mendez A, Wang H, et al. The Three Soxc Proteins—Sox4, Sox11 And Sox12—Exhibit Overlapping Expression Patterns And Molecular Properties. Nucleic Acids Res 2008; 36(9): 3101-17.
6. Hoser M, Potzner MR, Koch JM, et al. Sox12 Deletion In The Mouse Reveals Nonreciprocal Redundancy With The Related Sox4 And Sox11 Transcription Factors. Mol Cell Biol 2008; 28(15): 4675-87.
7. Bhattaram P, Penzo-Méndez A, Sock E, et al. Organogenesis Relies On Soxc Transcription Factors For The Survival Of Neural And Mesenchymal Progenitors. Nat Commun 2010; 1(1): 1-12.
8. Bergsland M, Werme M, Malewicz M, et al. The Establishment Of Neuronal Properties Is Controlled By Sox4 And Sox11. Genes Dev 2006; 20(24): 3475-86.
9. Huang W, Chen Z, Shang X, et al. Sox12, A Direct Target Of FoxQ1, Promotes Hepatocellular Carcinoma Metastasis Through Up‐Regulating Twist1 And FGFBP1. Hepatology 2015; 61(6): 1920-33.
10. Bansil S, Cook SD, Rohowsky‐Kochan C. Multiple Sclerosis: Immune Mechanism And Update On Current Therapies. Ann Neurol 1995; 37(Suppl 1): S87-101.
11. Sawcer S, Franklin RJ, Ban M. Multiple Sclerosis Genetics. Lancet Neurol 2014; 13(7): 700-9.
12. Patsopoulos NA. Genetics Of Multiple Sclerosis: An Overview And New Directions. Cold Spring Harb Perspect Med 2018; 8(7): a028951.
13. Goldenberg MM. Multiple Sclerosis Review. Pharm Therapeut 2012; 37(3): 175-84.
14. Thompson AJ, Reingold SC, Cohen JA. Applying The 2017 Mcdonald Diagnostic Criteria For Multiple Sclerosis–Authors' Reply. Lancet Neurol 2018; 17(6): 499-500.
15. Petzold A. Applying The 2017 Mcdonald Diagnostic Criteria For Multiple Sclerosis. Lancet Neurol 2018; 17(6): 496-7.
16. Kurtzke JF. On The Origin Of EDSS. Mult Scler Relat Disord 2015; 4(2): 95-103.
17. Smith E, Sigvardsson M. The Roles Of Transcription Factors In B Lymphocyte Commitment, Development, And Transformation. J Leukoc Biol 2004; 75(6): 973-81.
18. Cheung M, Abu-Elmagd M, Clevers H, et al. Roles Of Sox4 In Central Nervous System Development. Brain Res Mol Brain Res 2000; 79(1-2): 180-91.
19. Lee CJ, Appleby VJ, Orme AT, et al. Differential Expression Of Sox4 And Sox11 In Medulloblastoma. J Neurooncol 2002; 57(3): 201-14.
20. Usui A, Mochizuki Y, Iida A, et al. The Early Retinal Progenitor-Expressed Gene Sox11 Regulates The Timing Of The Differentiation Of Retinal Cells. Development 2013; 140(4): 740-50.
21. Sock E, Rettig SD, Enderich J, et al. Gene Targeting Reveals A Widespread Role For The High-Mobility-Group Transcription Factor Sox11 In Tissue Remodeling. Mol Cell Biol 2004; 24(15): 6635-44.
22. Penzo-Méndez AI. Critical Roles For Soxc Transcription Factors In Development And Cancer. Int J Biochem Cell Biol 2010; 42(3): 425-8.
23. Snider WD, Zhou FQ, Zhong J, et al. Signaling The Pathway To Regeneration. Neuron 2002; 35(1): 13-6.
24. Sun F, He Z. Neuronal Intrinsic Barriers For Axon Regeneration In The Adult CNS. Curr Opin Neurobiol 2010; 20(4): 510-8.
25. Abe N, Cavalli V. Nerve Injury Signaling. Curr Opin Neurobiol 2008; 18(3): 276-83.
26. Jenkins R, Hunt SP. Long-Term Increase In The Levels Of C-Jun Mrna And Jun Protein-Like Immunoreactivity In Motor And Sensory Neurons Following Axon Damage. Neurosci Lett 1991; 129(1): 107-10.
27. Kuwahara M, Yamashita M, Shinoda K, et al. The Transcription Factor Sox4 Is A Downstream Target Of Signaling By The Cytokine TGF-Β And Suppresses T(H)2 Differentiation. Nat Immunol 2012; 13(8): 778-86.
28. Dobolyi A, Vincze C, Pál G, et al. The Neuroprotective Functions Of Transforming Growth Factor Beta Proteins. Int J Mol Sci 2012; 13(7): 8219-58.
29. Li MO, Wan YY, Sanjabi S, et al. Transforming Growth Factor-Β Regulation Of Immune Responses. Annu Rev Immunol 2006; 24: 99-146.
30. Gorelik L, Flavell RA. Abrogation Of Tgfβ Signaling In T Cells Leads To Spontaneous T Cell Differentiation And Autoimmune Disease. Immunity 2000; 12(2): 171-81.
31. Meoli EM, Oh U, Grant CW, et al. TGF-Β Signaling Is Altered In The Peripheral Blood Of Subjects With Multiple Sclerosis. J Neuroimmunol 2011; 230(1-2): 164-8.
32. Li R, Bar-Or A. The Multiple Roles Of B Cells In Multiple Sclerosis And Their Implications In Multiple Sclerosis Therapies. Cold Spring Harb Perspect Med 2019; 9(4): 1-16.
33. Fillatreau S, Sweenie CH, Mcgeachy MJ, et al. B Cells Regulate Autoimmunity By Provision Of Il-10. Nat Immunol 2002; 3(10): 944-50.
34. Moghadasi M, Edalatmanesh M, Moeini A, et al. Effect Of 8 Weeks Resistance Training On Plasma Levels Of Nerve Growth Factor And Interlukin-6 In Female Patients With Multiple Sclerosis. Iran South Med J 2015; 18(3): 527-37. (Persian)
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
